510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K896194Substantially Equivalent

Captia(r) Cmv-G

Mercia Diagnostics, Ltd., Guildford, Surrey England, GB / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K896194 is the FDA 510(k) clearance record for CAPTIA(R) CMV-G, a class II device, cleared for Mercia Diagnostics , Ltd. on under FDA product code LFZ (Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus). FDA records list 17 510(k) clearances for Mercia Diagnostics , Ltd., from to . As of , FDA records show no recalls naming K896194.

Clearance record

Decision date
Received
(132 days to decision)
Product code
LFZ Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus
Regulation
21 CFR 866.3175
Device class
Class II
Review panel
Microbiology
Applicant
Mercia Diagnostics , Ltd. Mercia Houseet, Guildford, Surrey England, GB
Third party review
No

Clearances, product code LFZ

Trailing 12 months

FDA records hold no clearances under product code LFZ in the trailing twelve months.

FDA records show no clearances under product code LFZ in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LFZ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260